OsteoPrev - 120 CT by Ortho Molecular Products
OsteoPrev by Ortho Molecular Products is a bone health supplement designed to promote healthy bone density, increase skeletal strength, and improve bone remodeling.* This formulation includes Albion® TRAACS® chelated minerals, such as calcium, magnesium, copper, manganese, and molybdenum, for enhanced absorption.* OsteoPrev also contains calcium citrate-malate and calcium hydroxyapatite, which support optimal calcium utilization.* Magnesium plays a vital role in bone formation, while vitamins D3 and K work synergistically to improve calcium absorption and support bone strength.* Additionally, phytonutrients, boron, and phosphorus help with mineralization and reducing calcium loss.* OsteoPrev - 120 CT provides a comprehensive solution for maintaining bone density and supporting overall bone health.*
Who Should Consider OsteoPrev - 120 CT by Ortho Molecular Products?
OsteoPrev - 120 CT by Ortho Molecular Products may support your health if you:
- want to maintain healthy bone density*
- are post-menopausal or in need of additional bone support*
- want to improve skeletal strength*
OsteoPrev - 120 CT by Ortho Molecular Products —Effects?
OsteoPrev - 120 CT may:
- help with healthy bone density and mineralization*
- increase skeletal strength*
- support bone health*
- improve calcium absorption and utilization for optimal bone support*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about OsteoPrev - 120 CT by Ortho Molecular Products.
Recommendation:
Ortho Molecular Products suggests taking 4 capsules per day in divided doses or as recommended by your healthcare professional.
Serving size: 4
Servings per container: 30
Amount per serving:
Vitamin D3 (as Cholecalciferol) 1,000 IU
Vitamin K (500 mcg K1 as Phytonadione, 25 mcg K2 as Menaquinone-7 (MK-7)) 525 mcg
Folic Acid 800 mcg
Calcium 250 mg
(as Calcium Hydroxyapatite, DimaCal® Dicalcium Malate)
Phosphorus (as Calcium Hydroxyapatite) 110 mg
Magnesium 150 mg
(as DiMagnesium Malate, Magnesium Citrate USP, TRAACS® Magnesium Lysinate
Glycinate Chelate)
Selenium 200 mcg
(as Selenium Glycinate Complex)
Copper 1 mg
(as TRAACS® Copper Bisglycinate Chelate)
Manganese 10 mg
(as TRAACS® Manganese Bisglycinate Chelate)
Molybdenum 150 mcg
(as TRAACS® Molybdenum Glycinate Chelate)
Ipriflavone 600 mg
Boron (as Bororganic Glycine) 5 mg
Other ingredients: natural vegetable capsules, microcrystalline cellulose, turmeric root extract, magnesium stearate, and silicon dioxide.
Does not contain: gluten, yeast, artificial colors, artificial flavors
Cautions:
Do not consume OsteoPrev by Ortho Molecular Products if you are pregnant or nursing.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Click here to view Product Info Sheet
References:
- Agnusdei D, Bufalino L. (1997) Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int; 61 Suppl 1:S23-S27.
- Patrick Lyn. (1999) Comparative absorption of calcium sources and calcium citrate malate prevention for osteoporosis. Altern Med Review; 4(2):74-85.
- Johnson S. (2001) The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses; 56(2):163-70.
- Stendig-Lindberg G, Tepper R, Leichter I. (1993) Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res; 6:155-163.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr; 84:18-26.
- Wamberg L, Pedersen SB, Richelsen B, Rejnmark L. (2013) The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin D: results from a randomized controlled study. Calcif Tissue Int; 93(1):69-77.
- Cauley JA, Lacroix AZ, Wu L, Horwitz M, et al. (2008) Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med; 149(4):242-50.